Stem Cells cut new brain lesions in MSNew studies have proven that stem cell transplantation is much more effective than mitoxantrone for multiple sclerosis patients and their brain lesion. Italian researchers show that after undergoing stem cell treatments, patients had a lot less brain lesions than those on mitoxantrone. The reduction of new T2 lesion was astonishing 79%.
Giovanni Mancardi and his team from the University of Genova in Italy worked on this study for 4 years, whilst receiving support from the Italian Multiple Sclerosis Foundation. The focus was not on the later benefits of the stem cell treatment, but they found it evident that alongside fewer brain lesions , patients have less relapses annually, as well. The team believes that this treatment could easily be a lot more superior compared to the current treatments that are widely used for dealing with multiple sclerosis. It is also an option for all the patients who don’t respond to other treatments, said the team.
consultant@startstemcells.com
+381 62 256192